Clopidogrel with proton pump inhibitors: safe or not?

Area of Science:

• Pharmacology
• Gastroenterology
• Clinical Medicine

Background:

• Gastrointestinal (GI) bleeding is a significant risk with antiplatelet therapy.
• Proton pump inhibitors (PPIs) are used to mitigate this GI bleeding risk.
• Concerns exist regarding potential interactions between clopidogrel and PPIs, possibly reducing clopidogrel's effectiveness.

Purpose of the Study:

• To systematically review existing literature on the interaction between clopidogrel and PPIs.
• To evaluate the clinical evidence regarding the impact of PPIs on clopidogrel's antiplatelet activity and GI safety.

Main Methods:

• A web-based literature search was conducted using keywords: clopidogrel, omeprazole, proton pump inhibitors, and interaction.
• Eleven relevant studies were systematically reviewed and categorized by design (retrospective vs. prospective).

Main Results:

• Retrospective studies often indicated a link between clopidogrel and PPIs.
• Recent prospective studies found no significant interaction and highlighted PPIs' benefit in preventing GI side effects.
• Current clinical evidence for a clopidogrel-PPI interaction is insufficient.

Conclusions:

• The decision to co-administer PPIs with clopidogrel should be based on clinical indications for GI protection, not as a routine measure.
• Further research may be needed, but current evidence does not support routine prophylactic PPI use with clopidogrel due to interaction concerns.